Johnson and Johnson Up Against Deadline, U.S. Buys Pfizer Doses to Distribute Globally
Johnson and Johnson is up against a deadline as the United States is planning to distribute more Pfizer doses to other counties. Some states are reporting they have a surplus of Johnson and Johnson Covid-19 vaccine doses that are set to expire soon and the company and federal officials are looking at whether those expiration dates can be extended. Johnson and Johnson Chairman and CEO Alex Gorsky said “we’re working very hard, both at the federal level and at the local level, to do everything we can to make sure that these vaccines can be used and deployed in the very best possible way.” According to Dr. Anthony Fauci, the FDA is looking into extending the dates and how to make use of the doses. It’s unclear how many doses are set to expire before being used but according to the CDC, nearly 11 million doses, about half of the 21.4 million doses that have been delivered to states and other jurisdictions of the vaccine have not been administered.
The U.S. has purchased and will donate 500 million doses of the Pfizer Covid-19 vaccine worldwide. President Biden is set to announce the news at the G7 summit in Cornwall this week. Around 200 million doses will go out this year and an additional 300 million will be distributed in the first half of next year. All doses will go through COVAX, the international vaccine initiative.